Radiation resistance of nasopharyngeal carcinoma has been attributed to the PGC1α/C/EBPβ/CPT1A axis (103), and C/EBPβ is required for therapeutic resistance in NRF2-activated non-small cell lung cancer (104). This evidence concerns the gene PPARGC1A and non-small cell lung carcinoma.